Xeris Biopharma Holdings
XERS
XERS
97 hedge funds and large institutions have $71.6M invested in Xeris Biopharma Holdings in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 101 → 97 (-4)
20% less capital invested
Capital invested by funds: $89.3M → $71.6M (-$17.7M)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Holders
97
Holding in Top 10
2
Calls
$1.91M
Puts
$95K
Top Buyers
| 1 | +$923K | |
| 2 | +$462K | |
| 3 | +$251K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$117K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$106K |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$2.3M | |
| 3 | -$395K | |
| 4 |
DAM
Deltec Asset Management
New York
|
-$225K |
| 5 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$117K |